Cargando…

Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol

BACKGROUND: Gestational diabetes mellitus (GDM) increases the risk of adverse short- and long-term outcomes, including development of type 2 diabetes. The US Diabetes Prevention Program demonstrates this risk can be halved with an intensive health behavior change intervention in women with pre-diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Karoline Kragelund, O’Reilly, Sharleen, Wu, Nancy, Dasgupta, Kaberi, Maindal, Helle Terkildsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311057/
https://www.ncbi.nlm.nih.gov/pubmed/30594221
http://dx.doi.org/10.1186/s13063-018-3072-y
_version_ 1783383545571442688
author Nielsen, Karoline Kragelund
O’Reilly, Sharleen
Wu, Nancy
Dasgupta, Kaberi
Maindal, Helle Terkildsen
author_facet Nielsen, Karoline Kragelund
O’Reilly, Sharleen
Wu, Nancy
Dasgupta, Kaberi
Maindal, Helle Terkildsen
author_sort Nielsen, Karoline Kragelund
collection PubMed
description BACKGROUND: Gestational diabetes mellitus (GDM) increases the risk of adverse short- and long-term outcomes, including development of type 2 diabetes. The US Diabetes Prevention Program demonstrates this risk can be halved with an intensive health behavior change intervention in women with pre-diabetes averaging 12 years since a GDM pregnancy. In recent years, the number of studies looking at changing the behaviors of women with previous GDM closer to the time of delivery has steadily grown, but reported outcomes vary and most studies are not long enough or large enough to examine incident diabetes. This initiative aims to develop a core outcome set (COS) for interventions seeking to prevent diabetes after pregnancy (DAP) in both women with prior GDM and their families. METHODS: The COS-DAP project will use established COS methodology, in four stages: (1) a systematic literature review of DAP prevention intervention studies following GDM; (2) discussion and cataloguing of outcomes measured and implementation components at an investigator meeting; (3) a two-round online Delphi survey aimed at prioritizing the identified outcomes; and (4) a consensus meeting with key stakeholders to review, discuss, and refine suitable COS measures, using nominal group technique. DISCUSSION: COS-DAP aims to develop a COS for health behavior change interventions to prevent DAP. The COS is expected to enhance opportunities for comparison of future studies and allow for better synthesis of the effects. The inclusion of multiple stakeholder perspectives will increase the final COSs applicability and relevance. TRIAL REGISTRATION: Comet Initiative, COMET 1083; PROSPERO, CRD42018084853. Registered in prospero on 03/01/2018. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-3072-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6311057
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63110572019-01-07 Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol Nielsen, Karoline Kragelund O’Reilly, Sharleen Wu, Nancy Dasgupta, Kaberi Maindal, Helle Terkildsen Trials Study Protocol BACKGROUND: Gestational diabetes mellitus (GDM) increases the risk of adverse short- and long-term outcomes, including development of type 2 diabetes. The US Diabetes Prevention Program demonstrates this risk can be halved with an intensive health behavior change intervention in women with pre-diabetes averaging 12 years since a GDM pregnancy. In recent years, the number of studies looking at changing the behaviors of women with previous GDM closer to the time of delivery has steadily grown, but reported outcomes vary and most studies are not long enough or large enough to examine incident diabetes. This initiative aims to develop a core outcome set (COS) for interventions seeking to prevent diabetes after pregnancy (DAP) in both women with prior GDM and their families. METHODS: The COS-DAP project will use established COS methodology, in four stages: (1) a systematic literature review of DAP prevention intervention studies following GDM; (2) discussion and cataloguing of outcomes measured and implementation components at an investigator meeting; (3) a two-round online Delphi survey aimed at prioritizing the identified outcomes; and (4) a consensus meeting with key stakeholders to review, discuss, and refine suitable COS measures, using nominal group technique. DISCUSSION: COS-DAP aims to develop a COS for health behavior change interventions to prevent DAP. The COS is expected to enhance opportunities for comparison of future studies and allow for better synthesis of the effects. The inclusion of multiple stakeholder perspectives will increase the final COSs applicability and relevance. TRIAL REGISTRATION: Comet Initiative, COMET 1083; PROSPERO, CRD42018084853. Registered in prospero on 03/01/2018. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-3072-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-29 /pmc/articles/PMC6311057/ /pubmed/30594221 http://dx.doi.org/10.1186/s13063-018-3072-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Nielsen, Karoline Kragelund
O’Reilly, Sharleen
Wu, Nancy
Dasgupta, Kaberi
Maindal, Helle Terkildsen
Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol
title Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol
title_full Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol
title_fullStr Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol
title_full_unstemmed Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol
title_short Development of a core outcome set for diabetes after pregnancy prevention interventions (COS-DAP): a study protocol
title_sort development of a core outcome set for diabetes after pregnancy prevention interventions (cos-dap): a study protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311057/
https://www.ncbi.nlm.nih.gov/pubmed/30594221
http://dx.doi.org/10.1186/s13063-018-3072-y
work_keys_str_mv AT nielsenkarolinekragelund developmentofacoreoutcomesetfordiabetesafterpregnancypreventioninterventionscosdapastudyprotocol
AT oreillysharleen developmentofacoreoutcomesetfordiabetesafterpregnancypreventioninterventionscosdapastudyprotocol
AT wunancy developmentofacoreoutcomesetfordiabetesafterpregnancypreventioninterventionscosdapastudyprotocol
AT dasguptakaberi developmentofacoreoutcomesetfordiabetesafterpregnancypreventioninterventionscosdapastudyprotocol
AT maindalhelleterkildsen developmentofacoreoutcomesetfordiabetesafterpregnancypreventioninterventionscosdapastudyprotocol